Trial Profile
Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey on Long-term Use for in Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Pioglitazone/glimepiride (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 20 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Apr 2014 New trial record